ClinicalTrials.Veeva

Menu

Prevalence of CVC-associated Sepsis and Use of Blood Cultures in Berlin - Brandenburg

Charité University Medicine Berlin logo

Charité University Medicine Berlin

Status

Terminated

Conditions

Bacteremia

Study type

Observational

Funder types

Other

Identifiers

NCT01388686
BAC_BLOOD

Details and patient eligibility

About

Structured web-based survey in selected hospitals with intensive care units in Berlin- Brandenburg to collect data on the overall number of blood cultures (used) and the prevalence of (positive blood cultures in patients with) CVC - associated sepsis.

Full description

The use of CVC represents one of the major risk factors for sepsis, a highly prevalent disease in ICUs. Blood cultures obtained prior to antibiotic administration are part of the SSC Resuscitation Bundle and essential for the outcome of the patient. The CDC criteria to diagnose sepsis do not take into account the overall number of blood cultures obtained and thus, lead to an underestimation of the true incidence of sepsis. Up to now, few data is available on the total number of blood cultures obtained and the relation to the incidence of sepsis in German ICUs.

Enrollment

13 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Intensive care units of hospitals in the INABBRA alliance.
  • Patients with bacteremia.

Exclusion criteria

  • Hospitals without intensive care unit.

Trial design

13 participants in 1 patient group

INABBRA
Description:
Participating intensive care units of hospitals in the INABBRA alliance.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems